FDA considering accelerated approval of new Alzheimer?s drug
The FDA is considering accelerated approval of a new drug shown to attack amyloid plaque in the human brain, a contributing cause of cognitive dysfunction in dementia and Alzheimer?s disease.� The FDA is expected to reach a decision by Friday, January 6.
Top Videos
FDA considering accelerated approval of new Alzheimer?s drug
Minnesota Monster: The Teacher Who Abused 100+ Kids
Enough Said: Will the Vikings go 3-0 this Sunday?
Shots fired near Edina church
Vikings superfan turns front yard into massive tailgate
Walz pressed on nursing care law
MPS school closure plan explained
Downtown St. Paul's Ecolab Tower getting new life
Minnesota fraud: Nonprofit reaches $18.5M settlement
St. Paul mayor lawsuit: Full HR report has not been released
College QB from MN recovering from major head injury
White Bear Lake house fire that killed Jessi Pierce, 3 kids ruled accidental
Minnesota AG recovers $18.5M from child nutrition fraud settlement
New Richland flooding update: 'This community is tough'
Political Happy Hour: Deleted social media posts and debates
Vikings QB Kyler Murray returns from concussion: ‘It’s good to be back’
Minneapolis families demand answers after federal agent shootings
Northeast Minneapolis neighbors worried over construction
Serial child predator evaded accountability for years
Witness recounts shooting of Alexi Pretti by federal agents
Renee Good's mother testifies in Washington DC
P.J. Fleck Show: Gophers open Big Ten play at Washington
New Richland flooding: Biggest obstacle to prevention is funding
Manny Collins murder trial: Emotional outburst in courtroom at suspect
High diesel prices causing breweries to raise prices
